Consellería de Sanidade

2019

1. A model of indirect cell death caused by tumor vascular damage after high-dose radiotherapy

   Cancer Research, Vol. 79, Núm. 23, pp. 6044-6053

2. Are there enough radiation oncologists to lead the new Spanish radiotherapy?

   Clinical and Translational Oncology, Vol. 21, Núm. 12, pp. 1663-1672

3. Consensus on management of castration-resistant prostate cancer on behalf of the Urological Tumours Working Group (URONCOR) of the Spanish Society of Radiation Oncology

   Clinical and Translational Oncology, Vol. 21, Núm. 4, pp. 420-432

4. Correction to: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (Nature Genetics, (2018), 50, 7, (928-936), 10.1038/s41588-018-0142-8)

   Nature Genetics

5. Erratum to: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (Nature Communications, (2018), 9, 1, (4616), 10.1038/s41467-018-06863-1)

   Nature Communications

6. Late toxicity after single dose HDR prostate brachytherapy and EBRT for localized prostate cancer: Clinical and dosimetric predictors in a prospective cohort study

   Radiotherapy and Oncology, Vol. 135, pp. 13-18

7. Outcomes and prognostic factors in intermediate-risk prostate cancer: multi-institutional analysis of the Spanish RECAP database

   Clinical and Translational Oncology, Vol. 21, Núm. 7, pp. 900-909

8. REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

   Radiotherapy and Oncology, Vol. 138, pp. 59-67

9. Survival after biochemical failure in prostate cancer treated with radiotherapy: Spanish Registry of Prostate Cancer (RECAP) database outcomes

   Clinical and Translational Oncology, Vol. 21, Núm. 8, pp. 1044-1051